Subscribe To
Royalty pharma raises fy2023 guidance after $475m pfizer milestone payment
Royalty Pharma plc announced that it is raising its full year 2023 Adjusted Cash Receipts (non-GAAP) guidance to between $2.85 billion and $2.95 bill...
March 15, 2023, 11:42 am
2 top biotech stocks to buy right now
Sanofi and Amgen both have the two most important characteristics that investors should seek from pharmaceutic...
March 15, 2023, 9:30 am
Atossa to present at the sidoti small-cap virtual conference
SEATTLE, March 15, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biophar...
March 15, 2023, 9:25 am
Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting
Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody,...
March 15, 2023, 9:16 am
Lantern pharma to present at the american association for cancer research (aacr) annual meeting
DALLAS--(BUSINESS WIRE)---- $LTRN--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical...
March 15, 2023, 8:00 am
Is spdr s&p pharmaceuticals etf (xph) a strong etf right now?
Smart Beta ETF report for XPH...
March 15, 2023, 7:41 am
Mgc pharmaceuticals enrols first patient in data collection app as part of cannepil™ clinical trial
MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has enrolled the first patient in its proprietary...
March 15, 2023, 7:01 am
Theratechnologies to present preclinical data at aacr demonstrating synergy between th1902 and anti-pd-l1 immunotherapy in cold tumor model
MONTREAL, March 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a bio
March 14, 2023, 6:42 pm
Crispr therapeutics to present at the american association for cancer research 2023 annual meeting
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biophar...
March 14, 2023, 6:02 pm
Nuvalent to present new preclinical data on alk-selective inhibitor nvl-655 at aacr annual meeting 2023
CAMBRIDGE, Mass. , March 14, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceu...
March 14, 2023, 5:59 pm
Xencor to present preclinical data from novel xmab® cd28 bispecific antibody programs at the american association for cancer research annual meeting 2023
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical compa...
March 14, 2023, 4:31 pm
Adamis pharmaceuticals schedules fourth quarter and full year 2022 financial results conference call and corporate update
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis pharmaceuticals Corporation (NASDAQ: ADMP), a comm...
March 14, 2023, 4:01 pm
Johnson & johnson: creating shareholder value
Johnson & Johnson ( JNJ , Financial), one of the world's largest health care companies, has been making waves in the industry with its diverse ...
March 14, 2023, 3:42 pm
What makes theseus pharmaceuticals, inc. (thrx) a new buy stock
Theseus pharmaceuticals, Inc. (THRX) might move higher on growing optimism about its earnings prospects...
March 14, 2023, 1:44 pm
Aridis (ards) stock up as cystic fibrosis study meets goals
Aridis pharmaceuticals (ADRS) meets primary and secondary endpoints in a phase IIa study on AR-501 for ...
March 14, 2023, 1:44 pm
Monoclonal antibodies? avid bioservices surges 32% on blowout q3
Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodi...
March 14, 2023, 1:12 pm
Weather the fed with abbvie's strong portfolio and solid dividend growth
AbbVie's Humira sales may hold up better against biosimilars in the USA than they have in Europe. The pharmace...
March 14, 2023, 7:44 am
Deciphera pharmaceuticals, inc. (dcph) soars 10.3%: is further upside left in the stock?
Deciphera pharmaceuticals, Inc. (DCPH) saw its shares surge in the last session with trading volume bei...
March 14, 2023, 6:07 am
Stevanato group to present at keybanc capital markets life sciences & medtech investor forum
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnost...
March 14, 2023, 6:00 am
This biopharma stock jumped over 250% on monday: what happened?
Shares of Provention Bio Inc (NASDAQ: PRVB) more than tripled on Monday after Sanofi S.A. (EPA: SAN) confirmed plans of buying the bio...
March 13, 2023, 8:22 pm